Intel股价上涨五点四个百分点,马斯克Terafab合作进展备受关注
Intel股价上涨五点四个百分点,马斯克Terafab合作进展备受关注
Conclusion: The 5.49% gain is confirmed by the closing quote. The Musk–14A link is only partly confirmed: Musk has said Terafab plans to use Intel's 14A, and Intel is a named Terafab participant. But Intel has not disclosed a contract, volumes, or terms, and I found no source that ties the Monday move to a specific 14A report. For Intel's foundry, the news mainly helps credibility. It adds little to reported revenue in the near term, and execution risk remains high.
Data as of: US close on Monday, 9 November 2026 (16:00 ET). Web sources are dated as cited.
Market move (confirmed)
- INTC closed at , up from the prior close of . Quote timestamp: 2026-11-09 16:00 America/New_York.
- MarketBeat reports the move came "amid a broader chip-stock rebound," not a company-specific announcement. It also reports a $60.03 intraday high and volume about 21% above average.
What is confirmed about Musk and 14A
- Intel joined Terafab on 7 April 2026. Intel's X post said it would help "refactor silicon fab technology" with SpaceX, xAI and Tesla. It disclosed no financial terms, and no press release or SEC filing accompanied it (Reuters; Tom's Hardware).
- Musk said the plan was to use Intel 14A, on Tesla's April earnings call. This is Musk's statement, not an Intel-confirmed agreement (Motley Fool).
- SpaceX's IPO filing described Terafab as a general framework, with specific projects subject to separate agreements. It said neither Tesla nor Intel is obligated to stay in the project (Motley Fool, above).
- TSMC talks (3 October): Musk confirmed early talks, saying "something may come of it." A DailySynapse report says Terafab questioned whether Intel could deliver the expected 14A performance. Intel's CEO said the collaboration would continue (DailySynapse, 9 Oct). The performance claim is a press report, not verified.
- 9 November report: Nikkei, as relayed by Seoul Economic Daily, said Terafab is placing orders with Japanese equipment makers, targeting mass production in 2H 2028. Jiji Press reported the project is leaning toward Intel's 2nm or 1.4nm process. This is the closest match to the "14A factory" headline, but it is a press report, and Intel has not confirmed it (Seoul Economic Daily).
- Musk's 6 November remarks: At the Baron conference, Musk accepted a $1 trillion cost estimate for Terafab, to be spent in phases. Only the first phase, at more than $16.8 billion, has an official estimate. The first test chip is targeted for mid-2027, with volume in Q3 2028, which Musk called "very aggressive." He acknowledged the plan could fail (24/7 Wall St.).
Foundry credibility
- A Terafab win is a reputational endorsement of 14A. It is not yet a business relationship with defined economics.
- Intel's own 14A timeline is inconsistent across sources. One report puts risk production in 2H 2027 and another in Q2 2027, with volume in Q1 2028 (DailySynapse, 21 Sep; Baptista Research). I could not verify either against Intel's filings.
- Piper Sandler reportedly said Amazon, Apple, AMD, Google, Microsoft, Nvidia, Qualcomm and Tesla are evaluating 14A. Per the Motley Fool, no major outside company had publicly committed to 14A at Intel's own fabs as of 5 November.
- Intel's Q3 2026 results were strong. Revenue was $16.5B, non-GAAP gross margin 44.1%, and DCAI revenue $7.3B. Intel 18A and Intel 3 yields improved (TipRanks, Q3 call summary). The foundry still lost money. 24/7 Wall St. reports a loss of about $1.85B in Q3, which I could not confirm from a primary filing.
Future revenue
- Terafab is not in Intel's reported numbers. Its impact on near-term revenue is effectively nil. Mass production is targeted for 2028, and Musk's own 2027 volume timeline is described as aggressive.
- Foundry revenue is still small. Q2 2026 outside foundry revenue was about $293M, including $181M from Altera. Excluding Altera it was about $112M, roughly 2% of the $5.8B foundry revenue (Motley Fool).
- Licensing matters. Reports say Terafab wants to license 14A IP and run its own fabs. My inference: that model may yield IP fees or royalties rather than wafer volume at Intel-operated fabs. That is less valuable per unit of capacity than the outside foundry volume Intel needs.
- Valuation already assumes success. The Motley Fool cites about 57x 2027 earnings for Intel versus about 22x for TSMC. MarketBeat reports a Hold consensus with a $97.42 average target and several recent target cuts.
Execution and counterparty risk
- Timeline risk: Musk's schedule is compressed relative to industry norms. Japanese equipment makers reportedly see it as unusually fast.
- Funding risk: Tesla and SpaceX face heavy capex. SpaceX guided Q4 capex to $35–40B. Tesla and SpaceX special committees discussing a combination have not agreed terms. Equity raises would dilute shareholders.
- Counterparty risk: Intel is not obligated to stay in Terafab, and TSMC could take a larger role.
- Technology risk: Intel must prove 14A yields and defect density at scale. The reported defect-density target is 0.1–0.2 by Q1 2027, down from 0.5 in June 2026 (secondary report).
What would change the view: a signed Terafab agreement with disclosed economics, a named external 14A customer at Intel's own fabs, 14A risk-production milestones confirmed by Intel, or evidence that Terafab's TSMC talks have ended.
Sources
- Driven marketQuotes, INTC, 2026-11-09 16:00 ET (price, prior close, percent change)
- MarketBeat, 9 Nov 2026
- Seoul Economic Daily / Nikkei, 9 Nov 2026
- 24/7 Wall St., 7 Nov 2026
- Motley Fool, 5 Nov 2026 (updated)
- Baptista Research, 22 Oct 2026
- DailySynapse, 9 Oct 2026
- DailySynapse, 21 Sep 2026
- TipRanks, Intel Q3 2026 call summary
- Reuters, 7 Apr 2026
- Tom's Hardware, 7 Apr 2026